• 1. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 2. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 3. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 4. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 5. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides

Professional Introduction to Compound with CAS No. 36547-00-9 and Product Name: 2-sulfamoylbenzamide

Compound with the CAS number 36547-00-9, commonly known as 2-sulfamoylbenzamide, is a specialized chemical entity that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry. This compound belongs to the class of sulfonamides, which are well-documented for their diverse biological activities and therapeutic potential. The structural framework of 2-sulfamoylbenzamide consists of a benzamide moiety functionalized with a sulfamoyl group at the 2-position, making it a versatile scaffold for further chemical modifications and biological evaluations.

The significance of 2-sulfamoylbenzamide lies in its potential applications across multiple domains, particularly in medicinal chemistry and drug discovery. The sulfonamide group is renowned for its ability to interact with biological targets such as enzymes and receptors, often leading to the development of potent inhibitors. In recent years, there has been a surge in research focusing on sulfonamide derivatives due to their broad spectrum of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties.

Recent advancements in the field have highlighted the role of 2-sulfamoylbenzamide in the design of novel therapeutic agents. For instance, studies have demonstrated its efficacy in modulating enzyme activity by serving as a competitive inhibitor. This mechanism has been particularly explored in the context of kinases and other signaling enzymes that play crucial roles in various disease pathways. The benzamide moiety further enhances its pharmacological profile by contributing to metabolic stability and bioavailability, making it an attractive candidate for drug development.

One of the most compelling aspects of 2-sulfamoylbenzamide is its structural flexibility, which allows for extensive derivatization to tailor its biological properties. Researchers have been experimenting with various substituents on the benzene ring and the sulfonamide group to optimize potency, selectivity, and pharmacokinetic profiles. These modifications have led to the discovery of several promising lead compounds that are currently undergoing preclinical evaluations.

The synthesis of 2-sulfamoylbenzamide involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies have been employed to enhance yield and purity, ensuring that the final product meets stringent pharmaceutical standards. Techniques such as palladium-catalyzed cross-coupling reactions and enzymatic transformations have been particularly useful in constructing the complex scaffold of this compound.

In terms of biological activity, 2-sulfamoylbenzamide has shown notable effects in preclinical models. Its ability to inhibit specific enzymatic targets has been linked to potential therapeutic benefits in conditions such as cancer, inflammation, and infectious diseases. For example, studies have indicated that derivatives of 2-sulfamoylbenzamide can disrupt signaling pathways involved in tumor growth and progression. Additionally, its anti-inflammatory properties have been attributed to its interaction with inflammatory cytokines and mediators.

The pharmacokinetic behavior of 2-sulfamoylbenzamide is another critical area of investigation. Understanding how this compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for optimizing its therapeutic efficacy and minimizing side effects. Advanced computational modeling techniques have been utilized to predict ADME properties, aiding in the rational design of more effective sulfonamide-based drugs.

Future directions in the research of 2-sulfamoylbenzamide include exploring its potential in combination therapies. By pairing it with other bioactive molecules, researchers aim to achieve synergistic effects that could enhance treatment outcomes. Furthermore, there is growing interest in developing prodrugs based on 2-sulfamoylbenzamide to improve solubility and tissue penetration.

The industrial production of 2-sulfamoylbenzamide is also evolving with advancements in green chemistry principles. Efforts are being made to develop sustainable synthetic routes that minimize waste and reduce environmental impact. These initiatives align with global trends toward more eco-friendly pharmaceutical manufacturing processes.

Overall, compound with CAS No. 36547-00-9 (2-sulfamoylbenzamide) represents a significant asset in the pharmaceutical landscape due to its versatile structure and promising biological activities. Ongoing research continues to uncover new therapeutic applications for this compound, positioning it as a key player in next-generation drug development efforts.

• 102169-52-8(2-Hydrazinocarbonylbenzenesulfonamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)